Literature DB >> 17944998

Pharmacogenetic dose refinement prevents warfarin overdose in a patient who is highly warfarin-sensitive.

G R Grice, P E Milligan, C Eby, B F Gage.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17944998     DOI: 10.1111/j.1538-7836.2007.02797.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  2 in total

1.  Extreme sensitivity to acenocoumarol therapy in patient with both VKORC.-1639 A/A and CYP2C9*1/*3 genotypes.

Authors:  Mirjana K Kovac; Ljiljana B Rakicevic; Dragica P Radojkovic
Journal:  J Thromb Thrombolysis       Date:  2011-10       Impact factor: 2.300

2.  Warfarin Dosing in a Patient with CYP2C9(∗)3(∗)3 and VKORC1-1639 AA Genotypes.

Authors:  Mark Johnson; Craig Richard; Renee Bogdan; Robert Kidd
Journal:  Case Rep Genet       Date:  2014-01-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.